Product image of Norditropin Nordiflex (Somatropin) supplied by GNH India

Norditropin Nordiflex

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a recombinant human growth hormone presented as a solution for injection for subcutaneous use. It is prescribed to treat growth hormone deficiency in children and adults and is also indicated for Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency, and short stature associated with Noonan syndrome.

GNH India supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides cold‑chain logistics for biologic products.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Nordiflex, a recombinant human growth hormone, is used in conditions where growth promotion is required.

  • Growth hormone deficiency in children: improves linear growth and increases height velocity.
  • Growth hormone deficiency in adults: enhances body composition, bone density and metabolic profile.
  • Turner syndrome: supports growth and helps achieve near‑normal adult stature.
  • Prader‑Willi syndrome: contributes to increased height and improved body composition.
  • Chronic renal insufficiency: aids growth in pediatric patients with renal disease.
  • Short stature associated with Noonan syndrome: promotes growth and improves final height.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators that promote protein synthesis, linear bone growth, and lipolysis. Elevated IGF‑1 levels act on cartilage and muscle tissues to enhance cell proliferation and differentiation.

Side Effects

Somatropin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the injection site.
  • Headache: transient headache reported in some patients.
  • Joint stiffness: occasional arthralgia or reduced joint mobility.
  • Edema: peripheral swelling, especially in the ankles or hands.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include persistent headache, visual changes, or nausea.
  • Slipped epiphysis (growth plate fusion): may lead to abnormal bone growth.
  • Severe allergic reaction: rash, urticaria, or anaphylaxis requiring emergency care.
  • Hyperglycemia: elevated blood glucose levels, particularly in diabetic patients.

Precautions & Warnings

When prescribing Norditropin Nordiflex, clinicians should consider several safety measures.

  • Monitor blood glucose: patients with diabetes may experience hyperglycemia.
  • Assess thyroid function: growth hormone can affect thyroid hormone metabolism.
  • Screen for intracranial hypertension: watch for persistent headaches or visual disturbances.
  • Evaluate for scoliosis progression: growth acceleration may worsen spinal curvature.
  • Adjust dose in renal impairment: reduced clearance may alter drug exposure.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

  • Concurrent insulin therapy: increased risk of hypoglycemia.
  • High-dose glucocorticoids: may diminish growth hormone effectiveness.
  • Estrogen therapy: can elevate IGF‑1 levels, requiring dose adjustment.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may alter IGF‑1 concentrations, monitor clinical response.
  • Thyroid hormone replacement: growth hormone can increase thyroid hormone requirements.

Frequently Asked Questions

Norditropin Nordiflex is a recombinant human growth hormone indicated for treating growth hormone deficiency in children and adults, as well as for promoting growth in Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency, and short stature associated with Noonan syndrome.

Somatropin binds to growth hormone receptors, activating intracellular signaling that stimulates the liver to produce insulin‑like growth factor‑1 (IGF‑1). IGF‑1 then promotes protein synthesis, linear bone growth, and metabolic effects such as increased lipolysis and improved body composition.

The dose of Norditropin Nordiflex is individualized by the prescribing clinician based on factors such as the patient’s age, weight, severity of growth hormone deficiency, IGF‑1 levels, and response to therapy. No fixed regimen is provided publicly.

Safety of somatropin in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified health professional.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Norditropin Nordiflex is a recombinant somatropin formulation delivered as a ready‑to‑use solution for subcutaneous injection. Compared with lyophilized powders that require reconstitution, it offers convenience and reduced preparation time, while providing comparable efficacy and safety profiles to other approved growth hormone brands.

The product must be stored refrigerated at 2‑8 °C, protected from light. It should not be frozen or shaken. Once in use, the vial can be kept at room temperature for a limited period as specified in the product’s labeling.

Norditropin Nordiflex is administered by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The injection site should be rotated with each dose to minimize local reactions, and the solution is used directly from the pre‑filled device without further preparation.

Serious adverse events include intracranial hypertension, slipped epiphysis (premature closure of growth plates), severe allergic reactions such as anaphylaxis, and significant hyperglycemia, especially in patients with pre‑existing diabetes.

Norditropin Nordiflex is contraindicated in individuals with known hypersensitivity to somatropin or any excipients, active malignancy, or uncontrolled diabetic disease. Caution is also advised for patients with active proliferative retinopathy or severe acute illness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT